Monitoring DOAC levels not the answer

An increased risk of being rehospitalised for bleeding in people with non-valvular AF taking dabigatran compared to warfarin could be mitigated by monitoring drug plasma levels, researchers suggest. “Dabigatran works rapidly following its initiation; hence it may lead to more early-onset bleeds,” said Professor Chan, lead investigator on the study and Associate Professor in the department ...

Already a member?

Login to keep reading.

© 2021 the limbic